MedPath

A phase 2 study of choledochojejunostomy in pagients with locally advanced pancreatic adenocarcinoma undergoing chemo-proton therapy.

Phase 2
Conditions
locally advanced pancreatic cancer
Registration Number
JPRN-UMIN000030961
Lead Sponsor
Kobe University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
50
Inclusion Criteria

Not provided

Exclusion Criteria

1. Past history of choledochojejunostomy 2. History of diseases which cause bile duct stenosis 3. Past history of abdominal irradiation 4. Inability of solid oral intake 5. Uncontrollable diabetes mellitus 6. Sever complication(heart failure, renal failure,liver failure,intestinal paralysis etc) 7. Acute coronary syndrome within 6 months, severe arrythmia 8. Consistent steroid use 9. Severe mental disorder 10. doctors decision not to be registered to this study

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Incidence of unplanned delay or discontinuation of proton therapy
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath